Soleno Therapeutics Inc. appointed Jennifer Fulk as Chief Financial Officer, succeeding James Mackaness, who will retire by the end of the first quarter. Mackaness will remain a consultant through the end of the year to support the transition.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Soleno Therapeutics Inc. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.
Comments